An Efficacy and Safety of CNTO 1959 (Guselkumab) in Participants With Moderate to Severe Plaque-type Psoriasis
Clinical trial NCT02325219 · COMPLETED
Trial details
- NCT number
- NCT02325219
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-19
- Primary completion
- 2016-03-02
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.